These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28805292)

  • 61. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States.
    Tajima T; Martinez OM; Bernstein D; Boyd SD; Gratzinger D; Lum G; Sasaki K; Tan B; Twist CJ; Weinberg K; Armstrong B; Desai DM; Mazariegos GV; Chin C; Fishbein TM; Tekin A; Venick RS; Krams SM; Esquivel CO
    Pediatr Transplant; 2024 Jun; 28(4):e14763. PubMed ID: 38682750
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk of Kaposi sarcoma after solid organ transplantation in the United States.
    Cahoon EK; Linet MS; Clarke CA; Pawlish KS; Engels EA; Pfeiffer RM
    Int J Cancer; 2018 Dec; 143(11):2741-2748. PubMed ID: 29987894
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of antibody induction immunosuppression with cancer after kidney transplantation.
    Hall EC; Engels EA; Pfeiffer RM; Segev DL
    Transplantation; 2015 May; 99(5):1051-7. PubMed ID: 25340595
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients.
    Morton LM; Gibson TM; Clarke CA; Lynch CF; Weisenburger DD; Engels EA
    Haematologica; 2014 May; 99(5):70-3. PubMed ID: 24561790
    [No Abstract]   [Full Text] [Related]  

  • 65. Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
    Uldrick TS; Pipkin S; Scheer S; Hessol NA
    AIDS; 2014 Jan; 28(3):397-405. PubMed ID: 24076659
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elevated Risk of Cancer After Solid Organ Transplant in Childhood: A Population-based Cohort Study.
    Kitchlu A; Dixon S; Dirk JS; Chanchlani R; Vasilevska-Ristovska J; Borges K; Dipchand AI; Ng VL; Hebert D; Solomon M; Michael Paterson J; Gupta S; Joseph Kim S; Nathan PC; Parekh RS
    Transplantation; 2019 Mar; 103(3):588-596. PubMed ID: 30048393
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Primary central nervous system lymphoma.
    Batchelor TT
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):379-385. PubMed ID: 27913504
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
    Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.
    O'Neill BP; Decker PA; Tieu C; Cerhan JR
    Am J Hematol; 2013 Dec; 88(12):997-1000. PubMed ID: 23873804
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of primary CNS lymphoma (PCNSL) following successful treatment of systemic non-Hodgkin's lymphoma (NHL): a case series.
    Chamberlain MC
    J Neurooncol; 2013 May; 113(1):27-32. PubMed ID: 23456654
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.
    Coté TR; Biggar RJ; Rosenberg PS; Devesa SS; Percy C; Yellin FJ; Lemp G; Hardy C; Geodert JJ; Blattner WA
    Int J Cancer; 1997 Nov; 73(5):645-50. PubMed ID: 9398040
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Successful treatment of Epstein-Barr virus-associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein-Barr virus-specific T cells.
    Law SC; Hoang T; O'Rourke K; Tobin JWD; Gunawardana J; Loo-Oey D; Bednarska K; Merida de Long L; Sabdia MB; Hapgood G; Blyth E; Clancy L; Hennig S; Keane C; Gandhi MK
    Am J Transplant; 2021 Oct; 21(10):3465-3471. PubMed ID: 33942495
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of Cancer Diagnoses Between the US Solid Organ Transplant Registry and Linked Central Cancer Registries.
    Yanik EL; Nogueira LM; Koch L; Copeland G; Lynch CF; Pawlish KS; Finch JL; Kahn AR; Hernandez BY; Segev DL; Pfeiffer RM; Snyder JJ; Kasiske BL; Engels EA
    Am J Transplant; 2016 Oct; 16(10):2986-2993. PubMed ID: 27062091
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.
    Zhang X; Wu Y; Sun X; Cui Q; Bai X; Dong G; Gao Z; Wang Y; Gao C; Sun S; Ji N; Liu Y
    BMC Cancer; 2022 Feb; 22(1):190. PubMed ID: 35184749
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epstein-Barr virus-associated smooth muscle tumors after lung transplantation.
    Hirama T; Tikkanen J; Pal P; Cleary S; Binnie M
    Transpl Infect Dis; 2019 Jun; 21(3):e13068. PubMed ID: 30864272
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
    van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
    Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.
    Kinch A; Cavelier L; Bengtsson M; Baecklund E; Enblad G; Backlin C; Thunberg U; Sundström C; Pauksens K
    Am J Transplant; 2014 Dec; 14(12):2838-45. PubMed ID: 25307322
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival among patients with primary central nervous system lymphoma, 1973-2004.
    Norden AD; Drappatz J; Wen PY; Claus EB
    J Neurooncol; 2011 Feb; 101(3):487-93. PubMed ID: 20556477
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Donor Monoclonal Gammopathy May Cause Lymphoproliferative Disorders in Solid Organ Transplant Recipients.
    Felldin M; Ekberg J; Polanska-Tamborek D; Hansson U; Sender M; Rizell M; Svanvik J; Mölne J
    Am J Transplant; 2016 Sep; 16(9):2676-83. PubMed ID: 27575725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.